Septerna (SEPN) Non-cash Items (2023 - 2026)
Septerna (SEPN) recorded quarterly Non-cash Items of $60.5 million in Q1 2026, down 30.61% quarter-over-quarter from $87.2 million in Q4 2025, and up 8924.88% on a YoY basis from $670369.0 in Q1 2025.
Septerna (SEPN) Non-cash Items (2023 - 2026) Analysis & Trends
Septerna's Non-cash Items history runs 4 years deep, the most recent figure standing at $60.5 million for Q1 2026.
- In Q1 2026, Non-cash Items rose 8924.88% year-over-year to $60.5 million; the TTM figure through Mar 2026 stood at $60.5 million (up 8924.88% YoY), while the FY2025 annual figure was $87.2 million, up 16859.06% from the prior year.
- Non-cash Items was $60.5 million for Q1 2026 at Septerna, down from $87.2 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $87.2 million in Q4 2025 to a low of $670369.0 in Q1 2025.
- Historically, Non-cash Items has averaged $33.1 million across 4 years, with a median of $29.7 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Non-cash Items surged 62.35% in 2025, then jumped 8924.88% in 2026.
- A 4-year view of Non-cash Items shows it stood at $2.3 million in 2023, then jumped by 2248.32% to $53.7 million in 2024, then soared by 62.35% to $87.2 million in 2025, then plunged by 30.61% to $60.5 million in 2026.
- The last three Non-cash Items figures came in at $60.5 million (Q1 2026), $87.2 million (Q4 2025), and $49.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.50 Mn |
| Mar 31, 2026 | 60.50 Mn |
| Dec 31, 2025 | 87.19 Mn |
| Dec 31, 2025 | 87.19 Mn |
| Sep 30, 2025 | 49.20 Mn |
| Sep 30, 2025 | 49.20 Mn |
| Jun 30, 2025 | 728,861.00 |
| Jun 30, 2025 | 728,861.00 |
| Mar 31, 2025 | 670,369.00 |
| Mar 31, 2025 | 670,369.00 |
| Dec 31, 2024 | 53.71 Mn |
| Dec 31, 2024 | 53.71 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Dec 31, 2023 | 2.29 Mn |